Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

NXC vs BLK vs IVZ

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NXC
Nuveen California Select Tax-Free Income Portfolio

Asset Management - Income

Financial ServicesNYSE • US
Market Cap$86M
5Y Perf.-14.2%
BLK
BlackRock, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$165.65B
5Y Perf.+102.5%
IVZ
Invesco Ltd.

Asset Management

Financial ServicesNYSE • US
Market Cap$11.92B
5Y Perf.+229.6%

NXC vs BLK vs IVZ — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NXC logoNXC
BLK logoBLK
IVZ logoIVZ
IndustryAsset Management - IncomeAsset ManagementAsset Management
Market Cap$86M$165.65B$11.92B
Revenue (TTM)$4M$20.41B$6.38B
Net Income (TTM)$7M$6.10B$-243M
Gross Margin100.0%49.4%43.2%
Operating Margin90.8%37.1%-10.9%
Forward P/E38.0x20.4x10.7x
Total Debt$6K$14.22B$10.12B
Cash & Equiv.$391K$12.76B$1.98B

NXC vs BLK vs IVZLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NXC
BLK
IVZ
StockMay 20Jan 26Return
Nuveen California S… (NXC)10085.8-14.2%
BlackRock, Inc. (BLK)100202.5+102.5%
Invesco Ltd. (IVZ)100329.6+229.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: NXC vs BLK vs IVZ

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NXC leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. BlackRock, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
NXC
Nuveen California Select Tax-Free Income Portfolio
The Banking Pick

NXC has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.

  • Lower volatility, beta 0.04, Low D/E 0.0%, current ratio 4.13x
  • Efficiency ratio 0.1% vs IVZ's 0.5% (lower = leaner)
  • Beta 0.04 vs IVZ's 1.67, lower leverage
Best for: sleep-well-at-night
BLK
BlackRock, Inc.
The Banking Pick

BLK is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 15 yrs, beta 1.28, yield 1.9%
  • Rev growth 14.3%, EPS growth 15.1%
  • 245.8% 10Y total return vs IVZ's 22.1%
Best for: income & stability and growth exposure
IVZ
Invesco Ltd.
The Banking Pick

IVZ is the clearest fit if your priority is defensive.

  • Beta 1.67, yield 3.1%, current ratio 43.01x
  • Lower P/E (10.7x vs 20.4x)
  • +93.1% vs NXC's +4.2%
Best for: defensive
See the full category breakdown
CategoryWinnerWhy
GrowthBLK logoBLK14.3% NII/revenue growth vs NXC's -28.6%
ValueIVZ logoIVZLower P/E (10.7x vs 20.4x)
Quality / MarginsNXC logoNXCEfficiency ratio 0.1% vs IVZ's 0.5% (lower = leaner)
Stability / SafetyNXC logoNXCBeta 0.04 vs IVZ's 1.67, lower leverage
DividendsBLK logoBLK1.9% yield, 15-year raise streak, vs IVZ's 3.1%, (1 stock pays no dividend)
Momentum (1Y)IVZ logoIVZ+93.1% vs NXC's +4.2%
Efficiency (ROA)NXC logoNXCEfficiency ratio 0.1% vs IVZ's 0.5%

NXC vs BLK vs IVZ — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NXCNuveen California Select Tax-Free Income Portfolio

Segment breakdown not available.

BLKBlackRock, Inc.
FY 2024
Investment Advice
78.9%$16.1B
Technology Service
7.9%$1.6B
Distribution and Shareholder Service
6.2%$1.3B
Investment Performance
5.9%$1.2B
Service, Other
1.1%$224M
IVZInvesco Ltd.
FY 2025
Investment Advice
72.4%$4.6B
Distribution and Shareholder Service
23.8%$1.5B
Financial Service, Other
3.2%$202M
Investment Performance
0.7%$42M

NXC vs BLK vs IVZ — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLNXCLAGGINGBLK

Income & Cash Flow (Last 12 Months)

NXC leads this category, winning 3 of 5 comparable metrics.

BLK is the larger business by revenue, generating $20.4B annually — 5509.5x NXC's $4M. NXC is the more profitable business, keeping 60.7% of every revenue dollar as net income compared to IVZ's -4.4%.

MetricNXC logoNXCNuveen California…BLK logoBLKBlackRock, Inc.IVZ logoIVZInvesco Ltd.
RevenueTrailing 12 months$4M$20.4B$6.4B
EBITDAEarnings before interest/tax$7M$8.3B$1.2B
Net IncomeAfter-tax profit$7M$6.1B-$243M
Free Cash FlowCash after capex$0$3.9B$1.9B
Gross MarginGross profit ÷ Revenue+100.0%+49.4%+43.2%
Operating MarginEBIT ÷ Revenue+90.8%+37.1%-10.9%
Net MarginNet income ÷ Revenue+60.7%+31.2%-4.4%
FCF MarginFCF ÷ Revenue+23.0%+22.6%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-88.4%-22.7%+34.2%
NXC leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

IVZ leads this category, winning 6 of 6 comparable metrics.

At 25.4x trailing earnings, BLK trades at a 33% valuation discount to NXC's 38.0x P/E. On an enterprise value basis, IVZ's 16.3x EV/EBITDA is more attractive than BLK's 20.6x.

MetricNXC logoNXCNuveen California…BLK logoBLKBlackRock, Inc.IVZ logoIVZInvesco Ltd.
Market CapShares × price$86M$165.7B$11.9B
Enterprise ValueMkt cap + debt − cash$85M$167.1B$20.1B
Trailing P/EPrice ÷ TTM EPS37.97x25.42x-16.77x
Forward P/EPrice ÷ next-FY EPS est.20.42x10.73x
PEG RatioP/E ÷ EPS growth rate3.13x
EV / EBITDAEnterprise value multiple20.62x16.34x
Price / SalesMarket cap ÷ Revenue23.16x8.12x1.87x
Price / BookPrice ÷ Book value/share0.96x3.28x0.94x
Price / FCFMarket cap ÷ FCF35.24x8.27x
IVZ leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

NXC leads this category, winning 5 of 9 comparable metrics.

BLK delivers a 9.9% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-2 for IVZ. NXC carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x. On the Piotroski fundamental quality scale (0–9), BLK scores 6/9 vs NXC's 3/9, reflecting solid financial health.

MetricNXC logoNXCNuveen California…BLK logoBLKBlackRock, Inc.IVZ logoIVZInvesco Ltd.
ROE (TTM)Return on equity+8.3%+9.9%-1.7%
ROA (TTM)Return on assets+8.3%+3.7%-0.9%
ROICReturn on invested capital+2.8%+9.9%-2.3%
ROCEReturn on capital employed+3.8%+5.8%-2.6%
Piotroski ScoreFundamental quality 0–9366
Debt / EquityFinancial leverage0.00x0.29x0.78x
Net DebtTotal debt minus cash-$390,878$1.5B$8.1B
Cash & Equiv.Liquid assets$390,878$12.8B$2.0B
Total DebtShort + long-term debt$6,477$14.2B$10.1B
Interest CoverageEBIT ÷ Interest expense85.16x9.27x-6.19x
NXC leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

IVZ leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in BLK five years ago would be worth $13,352 today (with dividends reinvested), compared to $9,665 for NXC. Over the past 12 months, IVZ leads with a +93.1% total return vs NXC's +4.2%. The 3-year compound annual growth rate (CAGR) favors IVZ at 21.6% vs NXC's 3.1% — a key indicator of consistent wealth creation.

MetricNXC logoNXCNuveen California…BLK logoBLKBlackRock, Inc.IVZ logoIVZInvesco Ltd.
YTD ReturnYear-to-date+1.2%-1.1%+0.4%
1-Year ReturnPast 12 months+4.2%+18.3%+93.1%
3-Year ReturnCumulative with dividends+9.7%+75.7%+79.8%
5-Year ReturnCumulative with dividends-3.4%+33.5%+8.2%
10-Year ReturnCumulative with dividends+13.1%+245.8%+22.1%
CAGR (3Y)Annualised 3-year return+3.1%+20.7%+21.6%
IVZ leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

NXC leads this category, winning 2 of 2 comparable metrics.

NXC is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXC currently trades 98.8% from its 52-week high vs BLK's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNXC logoNXCNuveen California…BLK logoBLKBlackRock, Inc.IVZ logoIVZInvesco Ltd.
Beta (5Y)Sensitivity to S&P 5000.07x1.29x1.67x
52-Week HighHighest price in past year$13.45$1219.94$29.61
52-Week LowLowest price in past year$12.66$914.84$14.10
% of 52W HighCurrent price vs 52-week peak+98.8%+87.5%+90.6%
RSI (14)Momentum oscillator 0–10060.161.369.4
Avg Volume (50D)Average daily shares traded0790K5.1M
NXC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BLK and IVZ each lead in 1 of 2 comparable metrics.

Analyst consensus: BLK as "Buy", IVZ as "Hold". Consensus price targets imply 22.8% upside for BLK (target: $1312) vs 10.8% for IVZ (target: $30). For income investors, IVZ offers the higher dividend yield at 3.10% vs BLK's 1.92%.

MetricNXC logoNXCNuveen California…BLK logoBLKBlackRock, Inc.IVZ logoIVZInvesco Ltd.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$1311.78$29.72
# AnalystsCovering analysts3328
Dividend YieldAnnual dividend ÷ price+1.9%+3.1%
Dividend StreakConsecutive years of raises154
Dividend / ShareAnnual DPS$20.46$0.83
Buyback YieldShare repurchases ÷ mkt cap0.0%+1.2%+15.6%
Evenly matched — BLK and IVZ each lead in 1 of 2 comparable metrics.
Key Takeaway

NXC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IVZ leads in 2 (Valuation Metrics, Total Returns). 1 tied.

Best OverallNuveen California Select Ta… (NXC)Leads 3 of 6 categories
Loading custom metrics...

NXC vs BLK vs IVZ: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NXC or BLK or IVZ a better buy right now?

For growth investors, BlackRock, Inc.

(BLK) is the stronger pick with 14. 3% revenue growth year-over-year, versus -28. 6% for Nuveen California Select Tax-Free Income Portfolio (NXC). BlackRock, Inc. (BLK) offers the better valuation at 25. 4x trailing P/E (20. 4x forward), making it the more compelling value choice. Analysts rate BlackRock, Inc. (BLK) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NXC or BLK or IVZ?

On trailing P/E, BlackRock, Inc.

(BLK) is the cheapest at 25. 4x versus Nuveen California Select Tax-Free Income Portfolio at 38. 0x. On forward P/E, Invesco Ltd. is actually cheaper at 10. 7x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — NXC or BLK or IVZ?

Over the past 5 years, BlackRock, Inc.

(BLK) delivered a total return of +33. 5%, compared to -3. 4% for Nuveen California Select Tax-Free Income Portfolio (NXC). Over 10 years, the gap is even starker: BLK returned +250. 5% versus NXC's +13. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NXC or BLK or IVZ?

By beta (market sensitivity over 5 years), Nuveen California Select Tax-Free Income Portfolio (NXC) is the lower-risk stock at 0.

07β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 2435% more volatile than NXC relative to the S&P 500. On balance sheet safety, Nuveen California Select Tax-Free Income Portfolio (NXC) carries a lower debt/equity ratio of 0% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.

05

Which is growing faster — NXC or BLK or IVZ?

By revenue growth (latest reported year), BlackRock, Inc.

(BLK) is pulling ahead at 14. 3% versus -28. 6% for Nuveen California Select Tax-Free Income Portfolio (NXC). On earnings-per-share growth, the picture is similar: BlackRock, Inc. grew EPS 15. 1% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NXC or BLK or IVZ?

Nuveen California Select Tax-Free Income Portfolio (NXC) is the more profitable company, earning 60.

7% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 60. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NXC leads at 90. 8% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — NXC leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NXC or BLK or IVZ more undervalued right now?

On forward earnings alone, Invesco Ltd.

(IVZ) trades at 10. 7x forward P/E versus 20. 4x for BlackRock, Inc. — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLK: 22. 8% to $1311. 78.

08

Which pays a better dividend — NXC or BLK or IVZ?

In this comparison, IVZ (3.

1% yield), BLK (1. 9% yield) pay a dividend. NXC does not pay a meaningful dividend and should not be held primarily for income.

09

Is NXC or BLK or IVZ better for a retirement portfolio?

For long-horizon retirement investors, Nuveen California Select Tax-Free Income Portfolio (NXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

07)). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NXC: +13. 1%, IVZ: +24. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NXC and BLK and IVZ?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NXC is a small-cap quality compounder stock; BLK is a mid-cap quality compounder stock; IVZ is a mid-cap income-oriented stock. BLK, IVZ pay a dividend while NXC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NXC

Quality Mega-Cap Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 36%
Run This Screen
Stocks Like

BLK

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 18%
Run This Screen
Stocks Like

IVZ

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 25%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NXC and BLK and IVZ on the metrics below

Revenue Growth>
%
(NXC: -28.6% · BLK: 14.3%)
Net Margin>
%
(NXC: 60.7% · BLK: 31.2%)
P/E Ratio<
x
(NXC: 38.0x · BLK: 25.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.